TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.080
-0.010 (-0.92%)
At close: Dec 5, 2025, 4:00 PM EST
1.090
+0.010 (0.94%)
After-hours: Dec 5, 2025, 7:55 PM EST
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $61.29 million as of December 5, 2025. Its market cap has decreased by -72.72% in one year.
Market Cap
61.29M
Enterprise Value
-27.54M
1-Year Change
-72.72%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $61.29M, a decrease of -82.93%. That is a compound annual growth rate of -33.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 61.29M | -64.32% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 905.38B |
| Johnson & Johnson | 487.27B |
| AbbVie | 402.96B |
| UnitedHealth Group | 301.63B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.86B |
| Abbott Laboratories | 217.57B |